Therapeutic misconception—a false belief that individuals will benefit from participating in research—can bias informed consent. Ethics consultants can help by engaging participants’ and researchers’ understandings of risks and benefits and by asking good questions about the influences of researchers’ enthusiasm.

When a parent resists a physician's recommendation for a pediatric patient, physician-parent partnering can promote the patient's best interest and help encourage lifestyle changes.

When patients cannot give informed consent or refusal for antipsychotic medication, physicians must meet specific criteria to justify temporarily withholding a diagnosis.

Researchers and clinicians face ethical and policy-based challenges in disclosing, preventing and treating psychosis. Which diagnostic labels should be considered to motivate more effective public and professional dialogue about psychosis risk?

Word Choices is a mixed-media digital illustration that explores the importance of clinicians’ word choices during their encounters with patients. Clinicians often face ethical questions about sharing information with vulnerable patients.

Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research.

This image aims to promote reflection about patients’ feelings of sadness, despair, helplessness, and uncertainty upon being diagnosed.

The Code offers guidance about delivering a diagnosis and promoting patients’ best interests when assigning names to patients’ conditions.

Shared decision making in research informed consent conversations is complex due to diverse and potentially divergent interests of investigators and patient-subjects.

Although the stigma of the psychosis risk label can cause harm, the label can also confer benefit and provides an explanatory framework for symptoms.